Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
1.
Lupus ; 18(1): 78-80, 2009 Jan.
Article in English | MEDLINE | ID: mdl-19074173

ABSTRACT

We present a 43-year-old woman with relapsing-remitting multiple sclerosis (MS) who developed lupus syndrome after 32 months of IFN-beta-1a therapy. She presented with malaise, myalgia, arthralgia and fever. Laboratory tests showed high erythrocyte sedimentation rate, anaemia and lymphopenia. Antibodies to double stranded DNA (dsDNA) of IgG, IgM and IgA classes were detected on Critidia luciliae. Additionally, high levels of anti-nucleosomal antibodies, low levels of anti-histone and anti-Ro/SSA antibodies were also found. Diagnosis of drug-induced SLE was established. Treatment with IFN-beta was discontinued and oral prednisone was started. Twelve weeks after cessation of IFN-beta therapy, the patient's symptoms completely resolved and autoantibodies disappeared. To the best of our knowledge, this is the first report of a patient with MS in whom treatment with IFN-beta induced lupus syndrome and antibodies to dsDNA and nucleosome.


Subject(s)
Antibodies, Antinuclear/drug effects , Interferon-beta/adverse effects , Lupus Erythematosus, Systemic/chemically induced , Adjuvants, Immunologic/adverse effects , Adjuvants, Immunologic/therapeutic use , Adult , Antibodies, Antinuclear/metabolism , DNA/metabolism , Female , Glucocorticoids/therapeutic use , Humans , Interferon beta-1a , Interferon-beta/therapeutic use , Lupus Erythematosus, Systemic/physiopathology , Multiple Sclerosis/drug therapy , Prednisone/therapeutic use
2.
Lupus ; 16(10): 788-93, 2007.
Article in English | MEDLINE | ID: mdl-17895301

ABSTRACT

Antimitochondrial M5 type antibodies (AMA M5) have been described in patients with antiphospholipid syndrome (APS), thrombocytopenia and autoimmune hemolytic anemia. The aim of this study was to describe the clinical and immunological characteristics of a series of patients with AMA M5. We analyzed 71 patients with AMA M5 seen consecutively at our centres during the last 8 years. The clinical and immunological characteristics of diseases expression were compared with 70 consecutive disease control patients without AMA M5. Compared with the control group, AMA M5 positive patients presented higher prevalence of false positive VDRL test (P < 0.001) and thrombocytopenia (P = 0.002) with lower levels of anti-beta2 glycoprotein I antibodies. In AMA M5 patients (56 female, 15 male) a heterogeneous group of disorders were found. Twenty-seven (38%) patients fulfilled the Sapporo criteria for the classification of the APS. Laboratory criteria were met in 55 (77.5%), and clinical criteria in 31 (43.7%) patients. Six patients initially presented with non-criteria features of APS during follow-up period developed APS. Younger patients with AMA M5 should be carefully observed for the development of APS, even in the absence of serological criteria, while elderly must be screened for monoclonal gammopathy and hematological disorders.


Subject(s)
Autoantibodies/blood , Disease Susceptibility/immunology , Mitochondria/immunology , Adult , Age Factors , Aged , Antiphospholipid Syndrome/immunology , Autoimmune Diseases/immunology , Case-Control Studies , Female , Follow-Up Studies , Humans , Male , Middle Aged , Prevalence , Thrombocytopenia/immunology , beta 2-Glycoprotein I/immunology
3.
Clin Exp Rheumatol ; 25(3): 361-6, 2007.
Article in English | MEDLINE | ID: mdl-17631730

ABSTRACT

OBJECTIVE: The link between specific antibodies and atherogenesis in primary antiphospholipid syndrome (PAPS) is less strong than for thrombosis, although clearly the two processes are related and thrombosis is the main complication of atherosclerosis, a process known as atherothrombosis. The aim of this study was to investigate the influence of serum lipid levels and anti-oxidized LDL (oxLDL) antibodies on the clinical features of 42 patients with PAPS (mean age 40.45+/-13.37; 32 women and 10 men), and to compare them with 47 control subjects (mean age 39.68+/-13.93; 33 women and 14 men). METHODS: Total cholesterol, HDL and triglyceride concentrations were determined by enzymatic methods. LDL was calculated according to the Friedwald formula. Anticardiolipin, anti-oxidized LDL and anti-Beta2glycoprotein I antibodies were detected by ELISA. RESULTS: A significant association was found between arterial events and triglyceride, LDL and cholesterol concentrations, but multivariate analysis showed that cholesterol concentrations were the most important predictor of arterial events (p=0.012). Cerebrovascular insults were the most significantly associated with cholesterol concentrations (p=0.011). Myocardial infarctions were more frequently present in patients more than 40 years of age (p=0.032). No significant association of the investigated parameters with venous thromboses was found. Recurrent abortions were not associated with the presence or concentrations of the investigated parameters. Although patients had increased concentrations of anti-oxLDL antibodies, no significant association was found between the titres of anti-oxLDL antibodies and clinical features of APS. CONCLUSION: In patients with PAPS, lipid concentrations are a better predictor for arterial events than anti-oxLDL antibodies.


Subject(s)
Antibodies, Anti-Idiotypic/blood , Antiphospholipid Syndrome/blood , Lipids/blood , Lipoproteins, LDL/immunology , Adult , Aged , Antibodies, Anticardiolipin/blood , Antiphospholipid Syndrome/immunology , Atherosclerosis/etiology , Case-Control Studies , Female , Humans , Male , Middle Aged , Multivariate Analysis , Predictive Value of Tests , Risk Factors , Thrombosis/etiology , beta 2-Glycoprotein I/immunology
4.
Clin Exp Dermatol ; 28(2): 151-3, 2003 Mar.
Article in English | MEDLINE | ID: mdl-12653701

ABSTRACT

We report a 69-year-old Caucasian female with non-Hodgkin's lymphoma who subsequently developed leg ulcers as a manifestation of the antiphospholipid syndrome. Investigations revealed a mixed cryoglobulinaemia with monoclonal IgM-kappa and antiphospholipid activity with anticardiolipin antibodies, antimitochondrial type M5 antibodies and lupus anticoagulant. Significantly increased concentration of anticardiolipin antibodies was detected in the cryoprecipitate. Our case illustrates a connection between cryoglobulinaemia and lymphoproliferative and autoimmune disorders. Both cryoglobulins and anticardiolipin antibodies could participate in the vascular damage. Cutaneous manifestations in the presence of these disorders associated with non-Hodgkin's lymphoma have not been described previously.


Subject(s)
Antiphospholipid Syndrome/complications , Cryoglobulinemia/complications , Leg Ulcer/etiology , Purpura/etiology , Aged , Female , Humans , Lymphoma, Non-Hodgkin/complications , Salivary Gland Neoplasms/complications
5.
Clin Exp Rheumatol ; 20(4): 499-504, 2002.
Article in English | MEDLINE | ID: mdl-12175105

ABSTRACT

OBJECTIVE: Epidermal in vivo nuclear staining is occasionally noted in the lupus band test (LBT) in patients with connective tissue diseases (CTD). The exact clinical significance of this finding remains unelucidated, especially in association with a positive LBT We have reviewed the clinical and serological characteristics of patients with in vivo-bound antinuclear antibodies (ANA) in keratinocytes. METHODS: Between 1990-1999 speckled IgG staining in keratinocyte nuclei was observed in 31 LBT specimens. We had detailed clinical and laboratory data for 22/31 patients. The present study comprises 22 patients with in vivo-bound ANA (8 cases with mixed CTD (MCTD), 10 with systemic lupus erythematosus (SLE), 2 with Sjögren's syndrome (SS), one with undefined CTD and one clinically healthy mother of a child with neonatal lupus erythematosus), and 22 consecutive CTD patients (2 MCTD, 15 SLE, 5 SS) without in vivo-bound ANA. Antinuclear, anti-dsDNA and anti-extractable nuclear antigens (ENA) antibodies were determined using indirect immunofluorescence and ELISA methods. RESULTS: A significant difference (p < 0.01) in anti-RNP antibodies between patients with and without in vivo-bound ANA was observed. Consequently, there was a strong association of in vivo-bound ANA and anti-RNP antibodies (p < 0.01). In SLE patients with in vivo-bound ANA the incidence of nephropathy was significantly lower (p < 0.01), regardless of LBT positivity. In SLE patients there were no differences in LBT positivity, anti-dsDNA antibodies and complement consumption between groups. CONCLUSION: Our study implies that the presence of speckled ANA in keratinocytes in LBT may be useful in the diagnosis of MCTD and in the prognosis of renal involvement, especially in SLE patients.


Subject(s)
Antibodies, Antinuclear/metabolism , Keratinocytes/metabolism , Lupus Erythematosus, Cutaneous/metabolism , Adult , Female , Fluorescent Antibody Technique, Indirect , Humans , Immunoglobulin G/analysis , Keratinocytes/immunology , Keratinocytes/pathology , Lupus Erythematosus, Cutaneous/immunology , Lupus Erythematosus, Cutaneous/pathology , Lupus Erythematosus, Systemic/diagnosis , Lupus Erythematosus, Systemic/immunology , Lupus Erythematosus, Systemic/metabolism , Male , Mixed Connective Tissue Disease/immunology , Mixed Connective Tissue Disease/metabolism , Prognosis , Sjogren's Syndrome/immunology , Sjogren's Syndrome/metabolism , Staining and Labeling
6.
J Clin Pathol ; 54(5): 356-61, 2001 May.
Article in English | MEDLINE | ID: mdl-11328833

ABSTRACT

AIM: To develop a new, simple, and cheap method for estimating antioxidant activity in human fluids. METHODS: The assay measured the capacity of the biological fluids to inhibit the production of thiobarbituric acid reactive substances (TBARS) from sodium benzoate under the influence of the free oxygen radicals derived from Fenton's reaction. A solution of 1 mmol/litre uric acid was used as standard. RESULTS: The following mean (SD) antioxidative activities were found (as uric acid) in the various biological fluids: serum, 2.04 (0.20) mmol/litre; urine, 176.5 (25.6) micromol/litre; cerebrospinal fluid, 95.0 (26.9) micromol/litre; aqueous humour oculi, 61.25 (9.9) micromol/litre; saliva, 838.5 (48.2) micromol/litre; tears, 247.0 (17.0) micromol/litre; ascites fluid, 270.0 (63.3) micromol/litre; kidney cyst fluid, 387.1 (28.1) micromol/litre. Small samples of the biological material were needed for the analyses: 10 microl of serum and 50-100 microl of other body fluids. In the sera of 48 healthy individuals there was a significant positive correlation between values obtained with the Randox method (as a reference method) and the new method proposed here (correlation coefficient, 0.8728; mean difference between methods, <0.4%). CONCLUSIONS: This method is easy, rapid, reliable, and practical for the routine measurement of total antioxidant activity in serum and other human body fluids. Small samples of biological material are needed for the analyses and the results are comparable with the reference (Randox) method.


Subject(s)
Antioxidants/metabolism , Body Fluids/metabolism , Calibration , Dialysis , Free Radicals/pharmacology , Humans , Indicators and Reagents , Leukemia, Lymphocytic, Chronic, B-Cell/blood , Myocardial Infarction/blood , Oxidation-Reduction , Reaction Time , Reference Values , Reproducibility of Results , Sodium Benzoate/metabolism , Temperature , Thiobarbituric Acid Reactive Substances/metabolism , Time Factors , Tissue Preservation
10.
Srp Arh Celok Lek ; 126(3-4): 138-44, 1998.
Article in Serbian | MEDLINE | ID: mdl-9863370

ABSTRACT

Inflammatory response in tissue results from a complex network of interactions between inflammatory cells (mast cells, eosinophils, basophils, macrophages) and resident cells belonging to the lung structure (like endothelial cells, fibroblasts, epithelial cells). Among structural cells, endothelial cells play a critical role. The important role of endothelium is also reflected in the fact that it occupies an area exceeding 1000 m2. Thus, endothelium is the largest and the most active paracrine organ in the body, producing potent vasoactive, procoagulant, anticoagulant, and proinflammatory substances. Endothelial cells have four key functions that alter in the process of inflammation: 1 a) Regulation and control of leukocyte traffic through the expression of adhesion molecules (selectins E and P, molecules of immunoglobulin superfamily ICAM-1, ICAM-2, VCAM); 1 b) They are also able to amplify leukocyte activation through the production of proinflammatory cytokines like IL-1, IL-6 and chemokines like IL-8 and RANTES molecules; 2) Regulation of vascular tone by production of PGI-2, EDRF/NO and elements of local renin-angiotensin system; 3) Regulation of local coagulation by controlling the production of t-PA and PAI-1; 4) Regulation of the vascular permeability. In the states of acute inflammation, the endothelial cell takes on a proinflammatory phenotype and as such becomes chemoattractant, facilitating leukocyte adhesion, activation and migration, becomes prothrombotic and demonstrates enhanced vascular permeability.


Subject(s)
Endothelium, Vascular/physiopathology , Hypersensitivity/physiopathology , Capillary Permeability , Cell Adhesion Molecules/physiology , Endothelium, Vascular/metabolism , Humans , Inflammation , Inflammation Mediators/metabolism
11.
Srp Arh Celok Lek ; 126(9-10): 382-7, 1998.
Article in Serbian | MEDLINE | ID: mdl-9863412

ABSTRACT

Production of leukotrienes, lipooxygenase products of arachidonic acid metabolism, plays an important role in inflammatory reactions, particularly well studied in bronchial asthma. Lipooxigenase-5 and lipooxygenase-activating protein-5 are crucial in the production of leukotrienes with potent biological activities. Leukotriene B4 is a leukocytic chemoattractant and it induces aggregation and adherence of leukocytes to endothelial vasculature. Sulfidopeptid leukotrienes (C4, D4 and E4) are potent bronchoconstrictors, producing mucous secretion in the airways and increasing vascular permeability. Leukotrienes participate in the process of inflammation, as well as in early and late asthmatic responses. They are found in the blood, liquid obtained upon bronchoalveolar lavage as well as in the urine, irrespectively whether bronchospasm developed spontaneously or it was induced by an allergen. Administration of the specific leukotriene receptor antagonists or leukotriene synthesis inhibitors ameliorates the symptoms and signs of bronchial asthma.


Subject(s)
Asthma/physiopathology , Leukotrienes/physiology , Asthma/therapy , Humans , Inflammation , Inflammation Mediators/physiology
12.
Int J Cancer ; 76(6): 842-50, 1998 Jun 10.
Article in English | MEDLINE | ID: mdl-9626351

ABSTRACT

In a mode of nude mice bearing a human colon carcinoma xenograft, the biodistribution and tumor localization of metatetrahydroxyphenylchlorin (m-THPC) coupled to polyethylene glycol (PEG) were compared with those of the free form of this photosensitizer used in photodynamic therapy (PDT). At different times after i.v. injection of both forms of 125I-labeled photosensitizer, m-THPC-PEG gave on average a 2-fold higher tumor uptake than free m-THPC. In addition, at early times after injection, m-THPC-PEG showed a 2-fold longer blood circulating half-life and a 4-fold lower liver uptake than free m-THPC. The tumor to normal tissue ratios of radioactivity concentrations were always higher for m-THPC-PEG than for free m-THPC at any time point studied from 2 to 96 hr post-injection. Significant coefficients of correlation between direct fluorescence measurements and radioactivity counting were obtained within each organ tested. Fluorescence microscopy studies showed that m-THPC-PEG was preferentially localized near the tumor vessels, whereas m-THPC was more diffusely distributed inside the tumor tissue. To verify whether m-THPC-PEG conjugate remained phototoxic in vivo, PDT experiments were performed 72 hr after injection and showed that m-THPC-PEG was as potent as free m-THPC in the induction of tumor regression provided that the irradiation does for m-THPC-PEG conjugate was adapted to a well-tolerated 2-fold higher level. The overall results demonstrate first the possibility of improving the in vivo tumor localization of a hydrophobic dye used for PDT by coupling it to PEG and second that a photosensitizer conjugated to a macromolecule can remain phototoxic in vivo.


Subject(s)
Colonic Neoplasms/drug therapy , Mesoporphyrins/administration & dosage , Photochemotherapy , Photosensitizing Agents/administration & dosage , Polyethylene Glycols/administration & dosage , Animals , Half-Life , Humans , Iodine Radioisotopes , Mesoporphyrins/pharmacokinetics , Mice , Mice, Nude , Microscopy, Fluorescence , Neoplasm Transplantation , Transplantation, Heterologous
13.
Srp Arh Celok Lek ; 126(11-12): 499-505, 1998.
Article in Serbian | MEDLINE | ID: mdl-9921026

ABSTRACT

Monitoring of allergic inflammation includes direct examination of biopsy specimens from mucosa and epithelium, and indirect study by sputum, bronchoalveolar and nasal lavage fluid and peripheral blood. Although, some of these detection assays are not applicable to clinical use, it is now possible to measure a number of inflammatory mediators released from cells participating in allergic disease. The release of performed histamine from peripheral blood basophils challenged with specific antigen remains a valuable in vitro correlate of immediate hypersensitivity reactions. However, other mediators such as LTC4 and IL-4 are also generated by basophils upon IgE dependent activation. Tryptase and PGD2 are released from mast cells upon activation. Eosinophils contain in their granules proteins that cause damage to the bronchial epithelium: MBP and ECP. It is possible to measure soluble markers from other cells (T cells, macrophages, platelets, endothelial cells) involved in allergic inflammation. Detection of mediators have produced data that have significantly added to our understanding of the mechanisms and allowed better pharmacological control of allergic inflammation.


Subject(s)
Respiratory Hypersensitivity/diagnosis , Asthma/diagnosis , Asthma/immunology , Histamine Release , Humans , Inflammation , Inflammation Mediators/analysis , Respiratory Hypersensitivity/immunology , Respiratory Hypersensitivity/physiopathology
14.
Int J Neurosci ; 89(3-4): 153-64, 1997 Feb.
Article in English | MEDLINE | ID: mdl-9134453

ABSTRACT

Sera from Wistar rats subjected to different stress procedures were tested by ELISA for the presence of autoantibodies with specificity for neuron-specific enolase (NSE) and S100 protein that are preferentially localized in neurons and glia, respectively. Autoantibodies were present in sera of animals before exposure to stress, and raised with age. Anti-NSE and anti-S100 autoantibody levels were increased one day after termination of restraint (2 hours daily, 10 days) and electric tail shock (80 shocks daily, 19 days), and in fifth and tenth week of overcrowding stress. Differences between stressed and control animals were not present one month following restraint and electric tail shock and in twentieth week of overcrowding.


Subject(s)
Autoantibodies/immunology , Brain/immunology , Stress, Psychological/immunology , Animals , Autoantibodies/analysis , Crowding , Electroshock , Enzyme-Linked Immunosorbent Assay , Male , Phosphopyruvate Hydratase/immunology , Rats , Rats, Wistar , Restraint, Physical , S100 Proteins/immunology , Social Isolation
15.
Srp Arh Celok Lek ; 125(11-12): 363-9, 1997.
Article in Serbian | MEDLINE | ID: mdl-9480572

ABSTRACT

The human mast-cell population is composed of a heterogenous group of cells with respect to structure and function. Mast-cells can no longer be regarded simply as cells that initiate acute allergic reactions through the release of rapidly metabolized mediators, such as histamine and products of arachidonic acid oxidation. The production of a wide range of cytokines by mast-cells in the centre of the allergic inflammation. These cytokines influence migration and activation of other different cells including basophils and eosinophils and also lymphocytes, thus perpetuating allergic inflammation. Mediators release from human basophils are considered to contribute to the late phase of allergic response.


Subject(s)
Basophils/physiology , Hypersensitivity/physiopathology , Mast Cells/physiology , Animals , Humans , Inflammation/physiopathology , Inflammation Mediators/physiology
16.
J Photochem Photobiol B ; 36(2): 143-51, 1996 Nov.
Article in English | MEDLINE | ID: mdl-9002251

ABSTRACT

The influence of the time interval between dye administration and detection by fluorescence microscopy was assessed in "early" squamous cell carcinomas of the cheek pouch mucosa and different healthy tissues of the Syrian hamster. Following intracardiac injection of 0.15 mg (kg bodyweight)-1 of meso-tetra-hydroxyphenylchlorin (m-THPC), groups of three animals were sacrificed at different time intervals up to 30 days. A group of three non-injected animals was used to detect the endogene fluorescence of the corresponding normal tissues for autofluorescence subtraction. The following excised organs (oesophagus, trachea, liver, spleen, kidney, skin, striated muscle, healthy and tumoral cheek pouch mucosae) were fast frozen in liquid nitrogen and stored at -70 degrees C for fluorescence microscopy. The results show significant differences in the detectable m-THPC levels in different tissue layers (for instance, the epithelia and muscle of the oesophagus, trachea and cheek pouch) at different time intervals. These data indicate that pharmacokinetic studies may be useful for selecting the optimal time for the photodetection and phototherapy of cancer.


Subject(s)
Carcinoma, Squamous Cell/metabolism , Mesoporphyrins/pharmacokinetics , Radiation-Sensitizing Agents/pharmacokinetics , Animals , Carcinoma, Squamous Cell/chemically induced , Cheek , Cricetinae , Esophagus/metabolism , Male , Mesocricetus , Microscopy, Fluorescence , Mouth Mucosa/metabolism , Tissue Distribution
17.
Int J Exp Pathol ; 77(1): 7-14, 1996 Feb.
Article in English | MEDLINE | ID: mdl-8664146

ABSTRACT

To test and optimize photodynamic therapy of early cancers in the upper aero-digestive tract and oesophagus, we sought an appropriate animal model, which was found in the 7,12-dimethylbenz[a]anthracene-induced early squamous cell carcinoma in the Golden Syrian hamster. This chemically induced neoplasm is shown, by histology and immunohistochemistry, to pass through similar stages of early cancer development as its human counterpart. Its time sequence is highly reproducible, leading to a well differentiated carcinoma in situ and microinvasive carcinoma in the hamster cheek pouch over a period of 10 weeks.


Subject(s)
9,10-Dimethyl-1,2-benzanthracene/toxicity , Carcinogens/toxicity , Carcinoma, Squamous Cell/chemically induced , Disease Models, Animal , Esophageal Neoplasms/chemically induced , Animals , Carcinoma in Situ/chemically induced , Carcinoma in Situ/pathology , Carcinoma, Squamous Cell/pathology , Cheek/pathology , Cricetinae , Keratins/metabolism , Male , Mesocricetus , Mouth Neoplasms/chemically induced , Mouth Neoplasms/pathology , Neoplasm Invasiveness , Photochemotherapy , Precancerous Conditions/chemically induced , Precancerous Conditions/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...